1. A thin film solar cell module comprising:
a plurality of serially-connected solar cells disposed on a common substrate, each of the plurality of solar cells individually having:
a first electrode layer formed on the substrate;
a light absorbing semiconductor layer formed on the first electrode layer to receive incident light to generate electron-hole pairs by photovoltaic effect;
a second electrode layer formed on the light absorbing semiconductor layer;
wherein one of the plurality of solar cells corresponds to a positive electrode of the thin film solar cell module and another one of the plurality of solar cells corresponds to a negative electrode of the thin film solar cell module;
wherein a side edge of the light absorbing semiconductor layer of the solar cell corresponding to the positive electrode of the thin film solar cell module is provided with a first region and the first electrode layer of the solar cell corresponding to the positive electrode of the thin film solar cell module is directly and electrically contacted with the second electrode layer of the solar cell corresponding to the positive electrode of the thin film solar cell module through the first region;
wherein a side edge of the light absorbing semiconductor layer of the solar cell corresponding to the negative electrode of the thin film solar cell module is provided with a second region and the first electrode layer of the solar cell corresponding to the negative electrode of the thin film solar cell module is directly and electrically contacted with the second electrode layer of the solar cell corresponding to the negative electrode of the thin film solar cell module through the second region; and
wherein each of the first region and the second region is disposed with a current output element.
2. The thin film solar cell module according to claim 1, wherein the current output element is a soldering tin.
3. The thin film solar cell module according to claim 1, wherein the substrate is made from a material selected from the group consisting of soda-lime glass, low iron glass, and alkali-free glass.
4. The thin film solar cell module according to claim 1, wherein the light absorbing semiconductor layer is made from a material selected from the group consisting of amorphous silicon, polymorphous silicon, microcrystalline silicon (mc-Si) and microcrystalline silicon germanium (mc-SiGe).
5. The thin film solar cell module according to claim 1, wherein the first electrode layer is made of a transparent conductive oxide (TCO), selected from the group consisting of indium doped tin oxide (ITO), indium doped zinc oxide (IZO), aluminum doped zinc oxide (AZO), boron doped zinc oxide (BZO), gallium doped zinc oxide (GZO), and zinc oxide (ZnO).
6. The thin film solar cell module according to claim 1, wherein the second electrode layer is made from a material selected from the group consisting of a transparent conductive oxide (TCO), a metal and a metal-transparent-conductive-oxide complex.
7. The thin film solar cell module according to claim 6, wherein the transparent conductive oxide is made from a material selected from the group consisting of indium doped tin oxide (ITO), indium doped zinc oxide (IZO), aluminum doped zinc oxide (AZO), boron doped zinc oxide (BZO), gallium doped zinc oxide (GZO), and zinc oxide (ZnO).
8. The thin film solar cell module according to claim 6, wherein the metal is made from a material selected from the group consisting of aluminum (Al), nickel (Ni), gold (Au), silver (Ag), chromium (Cr), titanium (Ti), and palladium (Pd).
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An isolated polynucleotide, comprising a first nucleotide sequence encoding a Her2neu target antigen consisting of:
a) amino acid residues 634 to 683 of SEQ ID NO: 1 operatively linked to
b) amino acid residues 1035 to 1255 of SEQ ID NO: 1, wherein the Her2neu target antigen consists of the amino acid sequence as set forth in SEQ ID NO: 10.
2. The polynucleotide of claim 1, wherein the first nucleotide sequence consists of the nucleotide sequence as set forth in SEQ ID NO:9.
3. The polynucleotide of claim 1, further comprising a second nucleotide sequence, which is operatively linked to the first nucleotide sequence.
4. The polynucleotide of claim 3, wherein the second nucleotide sequence comprises an expression regulatory element.
5. The polynucleotide of claim 4, wherein the expression regulatory element is a transcriptional regulatory element, a translational regulatory element, or a combination thereof.
6. The polynucleotide of claim 3, wherein the second nucleotide sequence encodes a heterologous polypeptide.
7. The polynucleotide of claim 6, which encodes a fusion protein comprising the Her2neu target antigen and the heterologous polypeptide.
8. The polynucleotide of claim 6, wherein the polypeptide is an immunostimulatory polypeptide.
9. A isolated cell containing the polynucleotide of claim 1.
10. The cell of claim 9, which is a mammalian cell.
11. An isolated polynucleotide, comprising a first nucleotide sequence encoding a Her2neu target antigen consisting of:
a) amino acid residues 606 to 683 of SEQ ID NO:1 operatively linked to
b) amino acid residues 1035 to 1255 of SEQ ID NO:1.
12. A vector, comprising the polynucleotide of claim 1 or claim 11.
13. The vector of claim 12, which is an expression vector.
14. The vector of claim 13, wherein the expression vector is a mammalian cell expression vector.
15. The vector of claim 12, which is a viral vector.
16. The vector of claim 15, wherein the viral vector is an alphavirus vector.
17. The vector of claim 16, wherein the alphavirus vector is a Venezuelan equine encephalitis virus (VEE) vector.
18. The vector of claim 15, wherein the viral vector is a retrovirus vector, an adenovirus vector, an adeno-associated virus vector, or a vaccinia virus vector.
19. The vector of claim 12, which is a plasmid vector.
20. The vector of claim 19, wherein the plasmid vector is a viral vector plasmid.
21. A isolated host cell containing the vector of claim 12.
22. An isolated polypeptide comprising a Her2neu target antigen consisting of:
a) amino acid residues 634 to 683 of SEQ ID NO:1 operatively linked to
b) amino acid residues 1035 to 1255 of SEQ ID NO:1, wherein the Her2neu target antigen consists of the amino acid sequence as set forth in SEQ ID NO:10.
23. An isolated polypeptide comprising a Her2neu target antigen consisting of:
a) amino acid residues 606 to 683 of SEQ ID NO:1 operatively linked to
b) amino acid residues 1035 to 1255 of SEQ ID NO:1.